Sandoz Executive and Leadership Team

Yasuo Obata, the Interim Chief Financial Officer at Sandoz, directs financial operations and strategic fiscal planning. Overseeing the company's financial health, Obata ensures robust management of assets and liabilities. This leadership position involves close collaboration with regional finance teams to maintain consistent financial reporting standards across all markets. Obata's focus centers on optimizing financial performance and supporting Sandoz's mission to increase patient access to essential medicines. The Interim Chief Financial Officer's responsibilities include managing budgets, forecasting financial outcomes, and implementing cost-effective strategies to drive sustainable growth. Yasuo Obata's guidance is critical for navigating complex global financial landscapes and ensuring the company's long-term economic stability.

Martin Fournier, the Vice President, Finance & Chief Financial Officer at Sandoz, architects the company's comprehensive financial strategy and oversees all fiscal activities. Fournier directs global financial planning, resource allocation, and investment initiatives, ensuring alignment with Sandoz's core mission of providing accessible healthcare solutions. This role involves rigorous analysis of market trends and economic conditions to inform strategic decision-making and drive profitability. The Vice President, Finance & Chief Financial Officer also manages relationships with financial institutions and stakeholders, maintaining Sandoz's strong credit standing. Martin Fournier's leadership ensures the financial integrity and operational efficiency required to deliver high-quality generic medicines and biosimilars worldwide. His oversight extends to risk management and the implementation of financial controls that support Sandoz's expansion across therapeutic areas like oncology and immunology.

Sergio Santamaria, the Chief Financial Officer, Macc Region at Sandoz, spearheads financial management and strategic fiscal direction for the Macc region. Santamaria directs regional budgeting, financial forecasting, and performance analysis, ensuring robust fiscal health and operational efficiency within the designated markets. This leadership role involves close coordination with global finance teams to implement standardized financial practices and reporting protocols. The Chief Financial Officer, Macc Region's responsibilities include optimizing resource allocation and identifying opportunities for financial growth and cost savings. Sergio Santamaria's expertise is vital for navigating regional economic complexities and supporting Sandoz's commitment to expanding access to essential medicines. Santamaria drives financial strategies that bolster Sandoz's presence and impact across diverse therapeutic areas within the Macc region.

Boon Ee, the President, Cluster (Asia) at Sandoz, directs the strategic growth and operational execution across the Asian market cluster. Ee oversees all business functions within the region, driving market penetration and expanding access to Sandoz's portfolio of generic medicines and biosimilars. This leadership position involves fostering strong relationships with regional stakeholders, healthcare providers, and regulatory bodies to ensure compliance and market success. The President, Cluster (Asia)'s focus is on adapting global strategies to local market dynamics, identifying new opportunities, and enhancing Sandoz's impact in therapeutic areas such as oncology and immunology. Boon Ee's leadership is instrumental in navigating the diverse healthcare landscapes of Asia, ensuring Sandoz delivers on its mission to provide high-quality, affordable treatments to patients throughout the region.

Keren Haruvi, the President, Sandoz (North America) at Sandoz, leads the strategic direction and operational execution for the North American market. Haruvi directs all business activities, focusing on expanding patient access to high-quality generic medicines and biosimilars across the United States and Canada. This critical role involves navigating complex regulatory environments, fostering key partnerships with healthcare systems, and driving market growth in therapeutic areas including oncology, immunology, and cardiovascular health. The President, Sandoz (North America)'s responsibilities encompass overseeing sales, marketing, and market access functions to ensure Sandoz's continued success and impact. Keren Haruvi's leadership is pivotal in strengthening Sandoz's position as a leading provider of affordable and essential treatments, directly contributing to improved patient outcomes throughout North America.

Elena Morchenko, the Med at Sandoz, drives medical strategy and ensures the scientific integrity of Sandoz's product portfolio. Morchenko oversees the development and implementation of medical affairs initiatives, focusing on enhancing the understanding and appropriate use of generic medicines and biosimilars. This role involves close collaboration with research and development teams, as well as commercial functions, to align medical objectives with business goals. The Med's responsibilities include providing medical expertise across various therapeutic areas, such as oncology and immunology, and engaging with key opinion leaders. Elena Morchenko's leadership ensures that Sandoz's medical communications and educational programs are scientifically sound and effectively support patient access to critical treatments worldwide. Morchenko's contributions are vital for maintaining Sandoz's reputation as a trusted provider of high-quality healthcare solutions.

Biakmawi Phaipi, the Team Captain at Sandoz, leads a dedicated team focused on operational excellence and project execution. Phaipi directs team efforts, ensuring efficient workflow and the successful completion of assigned tasks within Sandoz's broader objectives. This role involves fostering a collaborative team environment and motivating members to achieve high performance standards. The Team Captain's responsibilities include coordinating team activities, resolving operational challenges, and ensuring adherence to project timelines and quality benchmarks. Biakmawi Phaipi's leadership contributes to the smooth functioning of departmental operations, supporting Sandoz's mission to deliver essential medicines and biosimilars globally. Phaipi's focus on teamwork and efficiency is integral to maintaining Sandoz's commitment to quality and patient access.